XRCC1 and hepatocellular carcinoma: Therefore, we hypothesize that the XRCC1 Gln/Gln genotype can be used as a negative indicator in liver cancer and that XRCC1 can serve as a potential indicator for clinical diagnosis and prognosis, as well as a new potential target for clinical treatment in HCC cases.